ON-DRUG, SINGLE SITE, FMRI AND BEHAVIOR ASSESSMENT OPTIMIZATION STUDY IN HEALTHY VOLUNTEERS

Completed

• Conditions: niet van toepassing; n/a

• Registration Number: NL-OMON42589
• Lead Sponsor: F. Hoffmann-La Roche Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 35

Inclusion Criteria

* willing to participate in this study
* healthy male or female
* age between 18 and 45 years of age, inclusive
* BMI between 18 and 30 kilograms/meter2, inclusive, body weight between 50 and 100 kilogram, inclusive
* non-smokers and smokers (smoke less than 11 cigarettes per day (or comparable amount of cigars or pipe)

Exclusion Criteria

Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>fMRI optimalisation</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n/a</p><br>